| Male oxidative stress infertility (MOSI): proposed terminology and clinical practice guidelines for management of idiopathic male infertility A Agarwal, N Parekh, MKP Selvam, R Henkel, R Shah, ST Homa, ... The world journal of men's health 37 (3), 296-312, 2019 | 399 | 2019 |
| Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis P Gazzaniga, A Gradilone, E De Berardinis, GM Busetto, C Raimondi, ... Annals of Oncology 23 (9), 2352-2356, 2012 | 129 | 2012 |
| Effect of metabolic and antioxidant supplementation on sperm parameters in oligo‐astheno‐teratozoospermia, with and without varicocele: A double‐blind placebo‐controlled study GM Busetto, A Agarwal, A Virmani, G Antonini, G Ragonesi, F Del Giudice, ... Andrologia 50 (3), e12927, 2018 | 118 | 2018 |
| Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer AFG Cicero, O Allkanjari, GM Busetto, T Cai, G Larganà, V Magri, ... Archivio Italiano di Urologia e Andrologia 91 (3), 2019 | 108 | 2019 |
| Circulating tumor cells detection has independent prognostic impact in high‐risk non‐muscle invasive bladder cancer P Gazzaniga, E de Berardinis, C Raimondi, A Gradilone, GM Busetto, ... International journal of cancer 135 (8), 1978-1982, 2014 | 103 | 2014 |
| Double‐blind, randomised, placebo‐controlled trial on the effect of L‐carnitine and L‐acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia S Micic, N Lalic, D Djordjevic, N Bojanic, N Bogavac‐Stanojevic, ... Andrologia 51 (6), e13267, 2019 | 101 | 2019 |
| Artificial intelligence and machine learning in prostate cancer patient management—current trends and future perspectives OS Tătaru, MD Vartolomei, JJ Rassweiler, O Virgil, G Lucarelli, F Porpiglia, ... Diagnostics 11 (2), 354, 2021 | 92 | 2021 |
| Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer: a systematic review and meta-analysis M Maggi, V Panebianco, A Mosca, S Salciccia, A Gentilucci, G Di Pierro, ... European urology focus 6 (3), 463-478, 2020 | 88 | 2020 |
| An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer M Ferro, MD Vartolomei, GI Russo, F Cantiello, ARA Farhan, ... World journal of urology 37, 507-514, 2019 | 84 | 2019 |
| Systemic inflammatory markers and oncologic outcomes in patients with high-risk non–muscle-invasive urothelial bladder cancer F Cantiello, GI Russo, MD Vartolomei, ARA Farhan, D Terracciano, ... European urology oncology 1 (5), 403-410, 2018 | 75 | 2018 |
| Radiomics in prostate cancer: An up-to-date review M Ferro, O de Cobelli, G Musi, F Del Giudice, G Carrieri, GM Busetto, ... Therapeutic Advances in Urology 14, 17562872221109020, 2022 | 73 | 2022 |
| Biomarkers in prostate cancer diagnosis: from current knowledge to the role of metabolomics and exosomes S Salciccia, AL Capriotti, A Laganà, S Fais, M Logozzi, E De Berardinis, ... International journal of molecular sciences 22 (9), 4367, 2021 | 73 | 2021 |
| Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: evaluation of efficacy, satisfaction profile and complications G Antonini, GM Busetto, E De Berardinis, R Giovannone, P Vicini, ... International Journal of Impotence Research 28 (1), 4-8, 2016 | 72 | 2016 |
| Liquid biopsy biomarkers in urine: a route towards molecular diagnosis and personalized medicine of bladder cancer M Ferro, E La Civita, A Liotti, M Cennamo, F Tortora, C Buonerba, ... Journal of personalized medicine 11 (3), 237, 2021 | 69 | 2021 |
| A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility F Del Giudice, GM Busetto, E De Berardinis, I Sperduti, M Ferro, M Maggi, ... Asian journal of andrology 22 (4), 360-367, 2020 | 69 | 2020 |
| Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non–muscle-invasive bladder cancer MD Vartolomei, M Ferro, F Cantiello, G Lucarelli, S Di Stasi, R Hurle, ... Clinical Genitourinary Cancer 16 (6), 445-452, 2018 | 66 | 2018 |
| Prostate cancer radiogenomics—from imaging to molecular characterization M Ferro, O de Cobelli, MD Vartolomei, G Lucarelli, F Crocetto, B Barone, ... International Journal of Molecular Sciences 22 (18), 9971, 2021 | 62 | 2021 |
| Preoperative detection of Vesical Imaging‐Reporting and Data System (VI‐RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder … F Del Giudice, C Leonardo, G Simone, M Pecoraro, E De Berardinis, ... BJU international 126 (5), 610-619, 2020 | 60 | 2020 |
| Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance M Ferro, G Lucarelli, D Bruzzese, G Di Lorenzo, S Perdonà, R Autorino, ... Oncotarget 8 (11), 18424, 2017 | 58 | 2017 |
| Liquid biopsy in bladder cancer: State of the art and future perspectives F Crocetto, B Barone, M Ferro, GM Busetto, E La Civita, C Buonerba, ... Critical Reviews in Oncology/Hematology 170, 103577, 2022 | 56 | 2022 |
